Alkermes vs Supernus
ALKS and SUPN side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALKS and SUPN compare
Supernus grew revenue faster over the last twelve months (16.3% versus 10.8% for Alkermes).
Supernus keeps more of each dollar of sales as profit, with a net margin of 32.8% compared with 4.0% at Alkermes.
Supernus scores higher on the StockData Score (6 against 5 for Alkermes), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALKS | SUPN |
|---|---|---|
| Size and price | ||
| Market cap | $8.0B | – |
| Share price | $47.89 | $29.45 |
| Change, 1 year | 46.7% | −4.6% |
| Change, 5 years | 106% | – |
| Beta (5Y) | 0.41 | 0.69 |
| Employees | 2,050 | 838 |
| StockData Score | ||
| Total score | 5 | 6 (better) |
| Valuation score | 0 | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 2 | 2 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 126× | – |
| P/S | 4.8× | – |
| P/B | 4.4× | – |
| EV/EBITDA | 49.6× | – |
| P/FCF | 36.2× | – |
| FCF yield | 2.8% | – |
| Fair value | $15.32 | – |
| Margin of safety | −213% | – |
| Growth | ||
| Revenue growth (TTM) | 10.8% | 16.3% (better) |
| Revenue growth, 5Y average | 7.3% | – |
| Net income growth (TTM) | −81.0% | 252% (better) |
| EPS growth (TTM) | −81.7% | 253% (better) |
| Profitability | ||
| Gross margin | 84.6% | 85.0% (better) |
| Operating margin | 7.0% | 40.6% (better) |
| Net margin | 4.0% | 32.8% (better) |
| FCF margin | 13.3% (better) | 2.3% |
| Return on equity | 3.9% | – |
| Return on invested capital | 4.9% | – |
| Financial health | ||
| Debt / equity | 0.83 | – |
| Net debt / EBITDA | 4.73 | 0.32 (better) |
| Interest coverage | 2.0× | 32.8× (better) |
| Current ratio | 2.30 (better) | 0.61 |
| Altman Z-score | 2.31 | – |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 106% | 104% |
| Held by insiders | 1.6% | 16.4% |
| Insider net buying, 12 months | −$10.1M | −$2.5M (better) |
| Short interest, % of float | 11.9% | – |
Go deeper
- ALKS stock overview
- ALKS income statement
- ALKS valuation and score
- SUPN stock overview
- SUPN income statement
- SUPN valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.